Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nexavar plus FOLFIRI in advanced colorectal cancer
NCT00839111Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Nov 2008
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in colorectal cancer (CRC), sponsored by Fudan University. Status: unknown.
02
Drugs
sorafenib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00839111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00839111.